Systems and methods for attenuating opioid-induced euphoria

MA40333AUndetermined Publication Date: 2016-03-17PURDUE PHARMA LP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA40333
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2014-10-17
Filing Date
2015-09-14
Publication Date
2016-03-17
Patent Text Reader

Abstract

Disclosed in certain embodiments is a method of attenuating or preventing opioid- induced euphoria comprising administering to a patient in need thereof an effective amount of buprenorphine.
Need to check novelty before this filing date? Find Prior Art